Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
glacieraminos.shop
Samples
Passed
Failed
Trust score updated: June 2, 2026 · 100% pass rate
Composite score based on 182 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 182 COAs attributed to this vendor. Last recomputed 2026-06-02.
Family owned company priding ourselves with honesty and transparency
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 15, 2026 | TESAMORELIN | HPLC purity | PASS | 99.77% | ILS Labs | Lot TES10GA-07 · Report ACC-2026-2274 |
| May 11, 2026 | Tirzepatide | HPLC purity | PASS | 99.85% | Kovera Labs | Lot TIR20GA-04 · Report ACC-2026-2154 |
| May 10, 2026 | KPV | HPLC purity | PASS | 99.21% | ILS Labs | Lot KPV10GA-03 · Report ACC-2026-2139 |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
PMB address (-0.03), New domain (-0.06), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| May 10, 2026 | LIPO-C | HPLC purity | PASS | 99.74% | Kovera Labs | Lot LPCGA-02 · Report ACC-2026-2138 |
| May 10, 2026 | KLOW | HPLC purity | PASS | 99.77% | Kovera Labs | Lot KLO80GA-04 · Report ACC-2026-2142 |
| Apr 9, 2026 | Melanotan-2 | HPLC purity | PASS | 99.919% | Kovera Labs | Lot MT210GA-03 · Report KVR-2026-D525D2 |
| Apr 7, 2026 | MOTS-c | HPLC purity | PASS | 99.949% | Kovera Labs | Lot MOT20GA-04 · Report KVR-2026-945E82 |
| Apr 7, 2026 | Epithalon | HPLC purity | PASS | 99.933% | Kovera Labs | Lot EPI10GA-02 · Report KVR-2026-D49607 |
| Apr 4, 2026 | Tesamorelin | HPLC purity | PASS | 99.936% | Kovera Labs | Lot TES10GA-06 · Report KVR-2026-E6C80D |
| Apr 4, 2026 | NAD+ | HPLC purity | PASS | 99.977% | Kovera Labs | Lot NADGA-04 · Report KVR-2026-F08276 |
| Apr 4, 2026 | GLP1-S | HPLC purity | PASS | 99.886% | Kovera Labs | Lot SM15GA-02 · Report KVR-2026-5DB5E9 |
| Mar 29, 2026 | 5-Amino-1MQ | HPLC purity | PASS | 99.927% | Kovera Labs | Lot 5AM10GA-02 · Report KVR-2026-FE228C |
| Mar 28, 2026 | GLP3-R | HPLC purity | PASS | 99.963% | Kovera Labs | Lot RET15GA-02 · Report KVR-2026-6F87EF |
| Mar 28, 2026 | Klow | HPLC purity | PASS | 99.706% | Kovera Labs | Lot KLO80GA-03 · Report KVR-2026-882CFD |
| Mar 28, 2026 | Tesamorelin | HPLC purity | PASS | 99.891% | Kovera Labs | Lot TES20GA-03 · Report KVR-2026-FCABA0 |
| Mar 27, 2026 | GLP3-R | HPLC purity | PASS | 99.922% | Kovera Labs | Lot RET60GA-06 · Report KVR-2026-8859EA |
| Mar 26, 2026 | Testagen | HPLC purity | PASS | 99.877% | Kovera Labs | Lot TST20GA-02 · Report KVR-2026-4F00AD |
| Mar 26, 2026 | BPC-157 | HPLC purity | PASS | 99.951% | Kovera Labs | Lot BPC10GA-05 · Report KVR-2026-9B15DA |
| Mar 26, 2026 | GLP3-R | HPLC purity | PASS | 99.958% | Kovera Labs | Lot RET50GA-02 · Report KVR-2026-5D8D49 |
| Mar 26, 2026 | GLP3-R | HPLC purity | PASS | 99.956% | Kovera Labs | Lot RET10GA-03 · Report KVR-2026-0D8A68 |
| Mar 26, 2026 | Sermorelin | HPLC purity | PASS | 99.982% | Kovera Labs | Lot SER10GA-02 · Report KVR-2026-5B0844 |
| Mar 25, 2026 | Cagrilintide | HPLC purity | PASS | 99.904% | Kovera Labs | Lot CAG5GA-02 · Report KVR-2026-24C40B |
| Mar 25, 2026 | ARA-290 | HPLC purity | PASS | 99.966% | Kovera Labs | Lot ARA10GA-01 · Report KVR-2026-4EC6DD |
| Mar 24, 2026 | GHKPV | HPLC purity | PASS | 99.846% | Kovera Labs | Lot GHKPVGA-01 · Report KVR-2026-AA3901 |
| Mar 24, 2026 | GLP2-T | HPLC purity | PASS | 99.94% | Kovera Labs | Lot TIR20GA-03 · Report KVR-2026-D37E90 |
| Mar 24, 2026 | GLP2-T | HPLC purity | PASS | 99.909% | Kovera Labs | Lot TIR10GA-04 · Report KVR-2026-936F7A |
| Mar 20, 2026 | Glutathione | HPLC purity | PASS | 99.935% | Kovera Labs | Lot GLU1.5GA-02 · Report KVR-2026-B59DFB |
| Mar 20, 2026 | Cartalax | HPLC purity | PASS | 99.97% | Kovera Labs | Lot CLX20GA-02 · Report KVR-2026-63ADE1 |
| Mar 20, 2026 | Retatrutide/Cagrilintide | HPLC purity | PASS | 99.724% | Kovera Labs | Lot RECA24GA-03 · Report KVR-2026-BD148E |
| Mar 13, 2026 | BPC-157 | HPLC purity | PASS | 99.945% | Kovera Labs | Lot BPC20GA-02 · Report KVR-2026-A3FE12 |
| Mar 13, 2026 | Semax/Selank | HPLC purity | PASS | 99.912% | Kovera Labs | Lot SXSK10GA-01 · Report KVR-2026-E75E1E |
| Mar 13, 2026 | CJC-1295 (No DAC)/Ipamorelin | HPLC purity | PASS | 99.916% | Kovera Labs | Lot CJIP10GA-03 · Report KVR-2026-F181B7 |
| Mar 13, 2026 | Retatrutide | HPLC purity | PASS | 99.949% | Kovera Labs | Lot RET20GA-02 · Report KVR-2026-5D41E5 |
| Mar 13, 2026 | SS-31 | HPLC purity | PASS | 99.974% | Kovera Labs | Lot MTP10GA-03 · Report KVR-2026-4C8CEF |
| Mar 13, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99.853% | Kovera Labs | Lot BPTB20GA-03 · Report KVR-2026-D90300 |
| Mar 11, 2026 | BPC-157 | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot BPC5002026-01 · Report V260218-22001 |
| Mar 7, 2026 | Kisspeptin-10 | HPLC purity | PASS | 99.897% | Kovera Labs | Lot KIS10GA-02 · Report KVR-2026-C9F7C3 |
| Mar 6, 2026 | Semax | HPLC purity | PASS | 99.968% | Kovera Labs | Lot SMXGA-02 · Report KVR-2026-28702E |
| Mar 5, 2026 | PT-141 | HPLC purity | PASS | 99.971% | Kovera Labs | Lot PT10GA-02 · Report KVR-2026-1BC9ED |
| Mar 5, 2026 | Tesamorelin/Ipamorelin | HPLC purity | PASS | 99.947% | Kovera Labs | Lot TEIPGA-03 · Report KVR-2026-63E0EC |
| Mar 5, 2026 | SLU-PP-332 | HPLC purity | PASS | 99.994% | Freedom Diagnostics | Lot 2026-SLU-1 · Report 2603050115 |
| Mar 5, 2026 | Ipamorelin | HPLC purity | PASS | 99.927% | Kovera Labs | Lot IPA10GA-02 · Report KVR-2026-A2ECAD |
| Mar 5, 2026 | Selank | HPLC purity | PASS | 99.944% | Kovera Labs | Lot SLKGA-02 · Report KVR-2026-B7DB00 |
| Mar 4, 2026 | Cagrilintide | HPLC purity | PASS | 99.931% | Kovera Labs | Lot CAG10GA-03 · Report KVR-2026-E654C3 |
| Mar 2, 2026 | Tesofensine | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot TES05002026-01 · Report V260218-22005 |
| Feb 23, 2026 | CJC-1295 DAC | HPLC purity | PASS | 99.852% | Kovera Labs | Lot CJCWDGA-01 · Report KVR-2026-85465F |
| Feb 19, 2026 | GHK-Cu | HPLC purity | PASS | 99.854% | Kovera Labs | Lot GHK50GA-02 · Report KVR-2026-1D4A0F |
| Feb 16, 2026 | Melanotan-2 | HPLC purity | PASS | 99.604% | Kovera Labs | Lot MT210GA-02 · Report KVR-2026-22AE95 |
| Feb 16, 2026 | Thymosin alpha-1 | HPLC purity | PASS | 99.679% | Kovera Labs | Lot TA10GA-03 · Report KVR-2026-AE8483 |
| Feb 11, 2026 | CJC-1295 | HPLC purity | PASS | 99.78% | Freedom Diagnostics | Lot CJCNDGA-01 · Report 2602110048 |